Your browser is no longer supported. Please, upgrade your browser.
Settings
CRL Charles River Laboratories International, Inc. daily Stock Chart
CRL [NYSE]
Charles River Laboratories International, Inc.
Index- P/E31.41 EPS (ttm)4.63 Insider Own0.10% Shs Outstand49.39M Perf Week-0.10%
Market Cap7.18B Forward P/E19.74 EPS next Y7.37 Insider Trans-18.02% Shs Float48.04M Perf Month10.26%
Income228.60M PEG2.75 EPS next Q1.83 Inst Own98.70% Short Float2.01% Perf Quarter8.92%
Sales2.53B P/S2.84 EPS this Y7.60% Inst Trans1.61% Short Ratio2.87 Perf Half Y13.99%
Book/sh31.39 P/B4.63 EPS next Y12.51% ROA5.40% Target Price151.00 Perf Year5.95%
Cash/sh3.35 P/C43.34 EPS next 5Y11.44% ROE16.20% 52W Range103.00 - 149.07 Perf YTD28.46%
Dividend- P/FCF24.36 EPS past 5Y15.80% ROI9.10% 52W High-2.93% Beta1.11
Dividend %- Quick Ratio1.20 Sales past 5Y14.20% Gross Margin36.40% 52W Low40.49% ATR2.83
Employees14700 Current Ratio1.40 Sales Q/Q14.10% Oper. Margin13.60% RSI (14)64.89 Volatility1.45% 2.16%
OptionableYes Debt/Eq1.25 EPS Q/Q25.50% Profit Margin9.10% Rel Volume0.81 Prev Close145.39
ShortableYes LT Debt/Eq1.23 EarningsNov 06 BMO Payout0.00% Avg Volume336.51K Price144.70
Recom2.20 SMA204.12% SMA507.66% SMA2006.58% Volume271,678 Change-0.47%
Oct-18-19Downgrade BofA/Merrill Buy → Neutral $150
Jun-10-19Initiated SVB Leerink Outperform $155
Apr-30-19Resumed Evercore ISI Outperform $160
Dec-14-18Initiated Deutsche Bank Buy
Oct-09-18Initiated UBS Neutral
Aug-23-18Upgrade Raymond James Mkt Perform → Outperform
Jul-17-18Upgrade RBC Capital Mkts Sector Perform → Outperform
Jun-15-18Upgrade KeyBanc Capital Mkts Sector Weight → Overweight
Feb-14-18Upgrade SunTrust Hold → Buy
Jan-22-18Downgrade SunTrust Buy → Hold
Jan-19-18Initiated Evercore ISI In-line $117
Dec-13-17Initiated Argus Buy $120
Sep-19-17Initiated RBC Capital Mkts Sector Perform $110
Dec-16-16Upgrade Goldman Sell → Neutral
Nov-30-16Upgrade Barclays Underweight → Equal Weight $65 → $77
Sep-06-16Downgrade UBS Neutral → Sell $83 → $78
Jun-21-16Initiated Credit Suisse Neutral $84
May-20-16Reiterated Barclays Underweight $60 → $65
Apr-26-16Initiated Gabelli & Co Buy $96
Jan-07-16Upgrade Wells Fargo Market Perform → Outperform
Dec-04-19 04:30PM  Charles River Laboratories Updates Tumor Model Compendium Business Wire
Dec-03-19 10:02AM  Hedge Funds Have Never Been This Bullish On Charles River Laboratories International Inc. (CRL) Insider Monkey
Nov-28-19 05:40AM  Can You Imagine How Chuffed Charles River Laboratories International's (NYSE:CRL) Shareholders Feel About Its 130% Share Price Gain? Simply Wall St.
Nov-12-19 04:36AM  Charles River Labs Won't See Its Narrow Trading Range Last Forever TheStreet.com
Nov-11-19 02:05PM  Edited Transcript of CRL earnings conference call or presentation 6-Nov-19 2:00pm GMT Thomson Reuters StreetEvents
08:30AM  Charles River Laboratories to Present at Upcoming Investor Conferences Business Wire
Nov-06-19 08:35AM  Charles River Laboratories (CRL) Q3 Earnings Beat Estimates Zacks
07:00AM  Charles River Laboratories Announces Third-Quarter 2019 Results Business Wire
Nov-05-19 10:40AM  Healthcare Stock Earnings Slated on Nov 6: HUM, ELAN & More Zacks
Oct-30-19 10:34AM  Charles River Laboratories (CRL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Oct-29-19 07:06AM  Should You Investigate Charles River Laboratories International, Inc. (NYSE:CRL) At US$131? Simply Wall St.
Oct-23-19 04:30PM  Charles River Laboratories Announces Closing of Senior Notes Offering Business Wire
Oct-21-19 04:30PM  Charles River Laboratories Schedules Third-Quarter 2019 Earnings Release and Conference Call Business Wire
09:11AM  Charles River Laboratories Int'l, Inc. -- Moody's rates Charles River's unsecured notes Ba3; Ba2 CFR affirmed Moody's
08:05AM  Charles River Laboratories Announces Offering of $500 Million of Senior Notes Business Wire
Oct-16-19 04:30PM  Charles River Laboratories Demonstrates Industry-Leading Research at Neuroscience 2019 Business Wire
Oct-15-19 12:35PM  Is Charles River Laboratories International Inc. (CRL) Going To Burn These Hedge Funds ?? Insider Monkey
Oct-09-19 09:18AM  Calculating The Fair Value Of Charles River Laboratories International, Inc. (NYSE:CRL) Simply Wall St.
Oct-08-19 10:36AM  LabCorp (LH) Names Two Leaders for Major Business Wings Zacks
Oct-04-19 11:00PM  Edited Transcript of CRL earnings conference call or presentation 31-Jul-19 12:30pm GMT Thomson Reuters StreetEvents
Oct-03-19 08:00AM  Charles River Laboratories Joins Dementia Consortium, Reaffirms Commitment to Neuroscience Research Business Wire
Oct-01-19 08:00AM  Charles River Laboratories Adds Virginia M. Wilson to Board of Directors Business Wire
Sep-19-19 10:44AM  Need To Know: Charles River Laboratories International, Inc. (NYSE:CRL) Insiders Have Been Selling Shares Simply Wall St.
Sep-09-19 08:00AM  Charles River Laboratories Announces Updates to Microbial Solutions Product Portfolio Business Wire
Sep-05-19 04:30PM  Charles River Laboratories to Host 3rd Annual World Congress Business Wire
Sep-04-19 09:00AM  What Makes Charles River (CRL) a New Buy Stock Zacks
Sep-03-19 04:30PM  Charles River Laboratories to Present at Baird and Morgan Stanley Investor Conferences Business Wire
Aug-30-19 07:45AM  How Good Is Charles River Laboratories International, Inc. (NYSE:CRL), When It Comes To ROE? Simply Wall St.
Aug-12-19 10:14AM  Is Charles River Laboratories International (NYSE:CRL) A Risky Investment? Simply Wall St.
Aug-01-19 02:17AM  Blue-blooded crabs at heart of pharma dispute on drug testing Reuters
02:00AM  FOCUS-Blue-blooded crabs at heart of pharma dispute on drug testing Reuters
Jul-31-19 07:23PM  Charles River Laboratories International Inc (CRL) Q2 2019 Earnings Call Transcript Motley Fool
08:25AM  Charles River Laboratories (CRL) Q2 Earnings Beat Estimates Zacks
07:00AM  Charles River Laboratories Announces Second-Quarter 2019 Results Business Wire
Jul-30-19 11:45AM  Healthcare Stock Q2 Earnings Due on Jul 31: HUM, AMED & More Zacks
Jul-24-19 10:32AM  Earnings Preview: Charles River Laboratories (CRL) Q2 Earnings Expected to Decline Zacks
07:24AM  Here's What We Think About Charles River Laboratories International, Inc.'s (NYSE:CRL) CEO Pay Simply Wall St.
Jul-16-19 04:15PM  Charles River Laboratories Schedules Second-Quarter 2019 Earnings Release and Conference Call Business Wire
Jul-09-19 08:00AM  Charles River Laboratories to Open Flexible Vivarium Space for Clients in South San Francisco Business Wire
Jun-20-19 01:33PM  Is Charles River Laboratories International Inc. (CRL) A Good Stock To Buy? Insider Monkey
Jun-14-19 03:02PM  Don't Jump Into Charles River Labs Just Yet TheStreet.com
Jun-03-19 08:30AM  Charles River Laboratories to Present at Jefferies and Goldman Sachs Investor Conferences Business Wire
May-20-19 06:43PM  Edited Transcript of CRL earnings conference call or presentation 7-May-19 12:30pm GMT Thomson Reuters StreetEvents
May-16-19 08:00AM  Charles River Laboratories Invests in Resero Analytics Business Wire
May-13-19 10:19AM  How Do Analysts See Charles River Laboratories International, Inc. (NYSE:CRL) Performing Over The Next Year? Simply Wall St.
May-07-19 04:13PM  Medical Stock Pummeled On China Trade Worries Wiping Out Earnings Beat Investor's Business Daily -5.66%
03:23PM  Charles River Laboratories International Inc (CRL) Q1 2019 Earnings Call Transcript Motley Fool
08:15AM  Charles River Laboratories (CRL) Beats Q1 Earnings and Revenue Estimates Zacks
07:11AM  Charles River: 1Q Earnings Snapshot Associated Press
07:00AM  Charles River Laboratories Announces First-Quarter 2019 Results Business Wire
May-03-19 03:18PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL GlobeNewswire
May-01-19 08:55PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL PR Newswire
Apr-30-19 02:39PM  Charles River Labs says its biotech, pharma clients' data was hacked American City Business Journals
10:32AM  Charles River Laboratories (CRL) Q1 Earnings Preview: What's in the Cards? Zacks
Apr-29-19 07:00AM  Charles River Laboratories Completes the Acquisition of Citoxlab Business Wire
Apr-22-19 01:12PM  Were Hedge Funds Right About Piling Into Charles River Laboratories International (CRL)? Insider Monkey
10:42AM  Here's How P/E Ratios Can Help Us Understand Charles River Laboratories International, Inc. (NYSE:CRL) Simply Wall St.
Apr-12-19 11:52AM  Top Ranked Growth Stocks to Buy for April 12th Zacks
10:32AM  Teladoc's Partnership to Form Pediatric Telehealth Platform Zacks
Apr-11-19 08:30AM  Charles River Laboratories Schedules First-Quarter 2019 Earnings Release and Conference Call Business Wire
Apr-09-19 08:00AM  Charles River Laboratories and CHDI Foundation Extend Huntingtons Disease Collaboration Business Wire
Apr-05-19 10:00AM  Charles River Laboratories (CRL) Is Up 2.99% in One Week: What You Should Know Zacks
Apr-04-19 10:41AM  Zacks.com featured highlights include: Cadence Design, LPL, Charles and Automatic Data Zacks
Apr-03-19 09:19AM  4 GARP Stocks for a Winning Portfolio Zacks
Apr-02-19 10:27AM  Top Ranked Growth Stocks to Buy for April 2nd Zacks
09:15AM  Charles River (CRL) Hits 52-Week High, Can the Run Continue? Zacks
Mar-26-19 08:00AM  Charles River Laboratories Highlights Commitment to Oncology Research at 2019 AACR Annual Meeting Business Wire
Mar-25-19 07:40AM  Report: Developing Opportunities within Bristol-Myers Squibb, AutoNation, FirstEnergy, Charles River Laboratories International, Yum! Brands, and AGNC Investment Future Expectations, Projections Moving into 2019 GlobeNewswire
Mar-18-19 11:18AM  Encouraging Near-Term Outlook for Medical Services Industry Zacks
Mar-15-19 10:00AM  At US$141, Is It Time To Put Charles River Laboratories International, Inc. (NYSE:CRL) On Your Watch List? Simply Wall St.
Mar-04-19 02:35PM  Why Charles River Labs Is the Biotech Stock to Buy: Jim Cramer TheStreet.com
09:20AM  The Zacks Analyst Blog Highlights: General Motors, Charles River, DSW, Shoe Carnival and Boingo Zacks
08:30AM  Charles River Laboratories to Present at Raymond James and Barclays Investor Conferences Business Wire
Mar-01-19 07:05AM  US Economy Had a Banner 2018: Top 5 Gainers Zacks
06:25AM  Edited Transcript of CRL earnings conference call or presentation 13-Feb-19 1:30pm GMT Thomson Reuters StreetEvents
Feb-27-19 09:57AM  The Zacks Analyst Blog Highlights: Celgene, Charles River Laboratories International, Catalent and Aeterna Zentaris Zacks
08:52AM  Charles River Laboratories Could Suffer a Pullback Before Moving Still Higher TheStreet.com
Feb-26-19 07:35PM  Cramer Remix: This tech stock is worth buying ahead of the 5G rollout CNBC
07:08PM  Charles River Laboratories CEO: The drug industry is benefiting from biotech and pharma CNBC Videos
08:55AM  4 Drug Stocks to Buy Despite Price Hearing Woes Zacks
Feb-25-19 09:15AM  Charles River (CRL) Hits Fresh High: Is There Still Room to Run? Zacks
Feb-23-19 08:40AM  What Are Analysts Saying About Charles River Laboratories International, Inc.s (NYSE:CRL) Growth? Simply Wall St.
Feb-14-19 01:17PM  Charles River Laboratories Int'l, Inc. -- Moody's says Charles River's acquisition of Citoxlab is credit negative Moody's
10:02AM  Smart medicine: AI plays an increasingly bigger role in health care American City Business Journals
Feb-13-19 07:16PM  Charles River Laboratories International Inc (CRL) Q4 2018 Earnings Conference Call Transcript Motley Fool +7.68%
08:20AM  Charles River Laboratories (CRL) Q4 Earnings and Revenues Surpass Estimates Zacks
07:28AM  Charles River: 4Q Earnings Snapshot Associated Press
07:01AM  Charles River Laboratories Announces Fourth-Quarter and Full-Year 2018 Results and Provides 2019 Guidance Business Wire
07:00AM  Charles River Laboratories Signs Binding Offer to Acquire Citoxlab Business Wire
Feb-06-19 10:30AM  Earnings Preview: Charles River Laboratories (CRL) Q4 Earnings Expected to Decline Zacks
Jan-31-19 07:46AM  Need To Know: Charles River Laboratories International, Inc. (NYSE:CRL) Insiders Have Been Selling Shares Simply Wall St.
Jan-30-19 08:00AM  Charles River Laboratories and Toxys Enter Agreement to Offer ToxTracker® in North America Business Wire
Jan-18-19 07:25AM  Consolidated Research: 2019 Summary Expectations for Electronic Arts, Charles River Laboratories International, Cooper-Standard, Five Below, Emerge Energy Services LP, and Hornbeck Offshore Services Fundamental Analysis, Key Performance Indications GlobeNewswire
Jan-17-19 08:30AM  Charles River Laboratories Schedules Fourth-Quarter 2018 Earnings and 2019 Guidance Release and Conference Call Business Wire
Jan-16-19 08:00AM  Charles River Laboratories Selected for 2019 Bloomberg Gender-Equality Index Business Wire
Jan-11-19 08:00AM  Charles River Laboratories and Atomwise Form a Strategic Alliance to Provide Integrated, Artificial Intelligence-Driven Drug Discovery Business Wire
Jan-09-19 06:50AM  Today's Research Reports on Trending Tickers: Syneos Health and Charles River Laboratories International ACCESSWIRE
Jan-08-19 10:30AM  What Did Charles River Laboratories International, Inc.s (NYSE:CRL) CEO Take Home Last Year? Simply Wall St.
Jan-07-19 08:00AM  Charles River Laboratories to Present at J.P. Morgan Healthcare Conference Business Wire
Dec-27-18 04:10PM  Why This IBD Stock Of The Day 'Continues To Push For New Highs' Investor's Business Daily
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services worldwide. It operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily purpose-bred rats and mice for use by researchers. It also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification of a druggable target through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as bioanalysis, drug metabolism, pharmacokinetics, safety pharmacology, toxicology, and pathology services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile biopharmaceuticals, and consumer products. It also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company serves biopharmaceutical companies; biotechnology, agricultural and industrial chemical, life science, veterinary medicine, medical device, diagnostic, and consumer product companies; contract research and contract manufacturing organizations; other commercial entities; and hospitals, academic institutions, and government agencies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Girshick BirgitCorporate Executive VPNov 13Option Exercise91.199,604875,77833,664Nov 14 05:21 PM
Girshick BirgitCorporate Executive VPNov 13Sale137.231,499205,71224,060Nov 14 05:23 PM
Girshick BirgitCorporate Executive VPNov 13Sale137.048,1051,110,71725,559Nov 14 05:21 PM
Smith David RossCorporate Executive VP & CFOAug 12Option Exercise76.121,24995,07419,327Aug 13 03:32 PM
Smith David RossCorporate Executive VP & CFOAug 12Sale130.361,249162,82118,078Aug 13 03:32 PM
Barbo William DCorporate Executive VP & CCOMay 29Option Exercise76.672,158165,45425,859May 30 08:56 AM
Barbo William DCorporate Executive VP & CCOMay 29Sale125.961,253157,83019,701May 30 08:57 AM
Barbo William DCorporate Executive VP & CCOMay 29Sale125.164,905613,91920,954May 30 08:56 AM
MASSARO GEORGEDirectorMay 15Sale131.381,002131,64310,202May 16 10:15 AM
MASSARO GEORGEDirectorMay 10Option Exercise70.293,140220,71115,344May 13 12:52 PM
MASSARO GEORGEDirectorMay 10Sale134.643,140422,76912,204May 13 12:52 PM
LaPlume Joseph WEVP, Corp Strategy & DevelopMar 08Option Exercise88.2711,5881,022,91626,371Mar 12 07:57 AM
LaPlume Joseph WEVP, Corp Strategy & DevelopMar 08Sale138.231,666230,29513,413Mar 12 08:00 AM
LaPlume Joseph WEVP, Corp Strategy & DevelopMar 08Sale138.015,770796,33715,079Mar 12 07:58 AM
LaPlume Joseph WEVP, Corp Strategy & DevelopMar 08Sale137.615,522759,89220,849Mar 12 07:57 AM
Barbo William DCorporate Executive VP & CCOFeb 27Option Exercise83.3420,2011,683,55548,402Mar 01 11:05 AM
Smith David RossCorporate Executive VP & CFOFeb 27Option Exercise76.672,158165,45420,573Mar 01 11:42 AM
FOSTER JAMES CChairman, President and CEOFeb 27Option Exercise76.6721,5771,654,309300,777Mar 01 11:13 AM
Barbo William DCorporate Executive VP & CCOFeb 27Sale141.038,1551,150,07223,701Mar 01 11:08 AM
Barbo William DCorporate Executive VP & CCOFeb 27Sale140.6911,2221,578,85231,856Mar 01 11:06 AM
Barbo William DCorporate Executive VP & CCOFeb 27Sale140.485,324747,92143,078Mar 01 11:05 AM
FOSTER JAMES CChairman, President and CEOFeb 27Sale142.4951373,095279,200Mar 01 11:22 AM
FOSTER JAMES CChairman, President and CEOFeb 27Sale142.063,312470,516279,713Mar 01 11:21 AM
FOSTER JAMES CChairman, President and CEOFeb 27Sale141.743,263462,513283,025Mar 01 11:20 AM
FOSTER JAMES CChairman, President and CEOFeb 27Sale141.392,699381,614286,288Mar 01 11:19 AM
FOSTER JAMES CChairman, President and CEOFeb 27Sale140.844,374616,019288,987Mar 01 11:17 AM
FOSTER JAMES CChairman, President and CEOFeb 27Sale140.553,957556,159293,361Mar 01 11:16 AM
FOSTER JAMES CChairman, President and CEOFeb 27Sale140.243,459485,077297,318Mar 01 11:13 AM
Smith David RossCorporate Executive VP & CFOFeb 27Sale141.072,158304,43518,415Mar 01 11:42 AM
Smith David RossCorporate Executive VP & CFOFeb 26Option Exercise73.704,187308,58224,270Feb 28 09:21 AM
FOSTER JAMES CChairman, President and CEOFeb 26Option Exercise73.7025,1231,851,565306,494Feb 28 09:42 AM
FOSTER JAMES CChairman, President and CEOFeb 26Sale143.711,630234,250281,371Feb 28 09:55 AM
FOSTER JAMES CChairman, President and CEOFeb 26Sale141.753,756532,396283,001Feb 28 09:53 AM
FOSTER JAMES CChairman, President and CEOFeb 26Sale140.533,358471,889286,757Feb 28 09:52 AM
FOSTER JAMES CChairman, President and CEOFeb 26Sale140.253,673515,131290,115Feb 28 09:51 AM
FOSTER JAMES CChairman, President and CEOFeb 26Sale139.943,499489,648293,788Feb 28 09:49 AM
FOSTER JAMES CChairman, President and CEOFeb 26Sale139.725,072708,659297,287Feb 28 09:43 AM
FOSTER JAMES CChairman, President and CEOFeb 26Sale139.524,135576,905302,359Feb 28 09:42 AM
Smith David RossCorporate Executive VP & CFOFeb 26Sale141.511,587224,57918,633Feb 28 09:23 AM
Smith David RossCorporate Executive VP & CFOFeb 26Sale139.764,050566,01520,220Feb 28 09:21 AM
FOSTER JAMES CChairman, President and CEOFeb 25Option Exercise97.8044,3034,332,960327,947Feb 26 03:45 PM
Smith David RossCorporate Executive VP & CFOFeb 25Option Exercise98.028,210804,75128,672Feb 26 04:02 PM
FOSTER JAMES CChairman, President and CEOFeb 25Sale146.023,000438,057283,644Feb 26 03:56 PM
FOSTER JAMES CChairman, President and CEOFeb 25Sale145.784,076594,214286,644Feb 26 03:55 PM
FOSTER JAMES CChairman, President and CEOFeb 25Sale145.405,002727,275290,720Feb 26 03:53 PM
FOSTER JAMES CChairman, President and CEOFeb 25Sale145.205,966866,248295,722Feb 26 03:52 PM
FOSTER JAMES CChairman, President and CEOFeb 25Sale144.914,036584,847301,688Feb 26 03:51 PM
FOSTER JAMES CChairman, President and CEOFeb 25Sale144.697,6431,105,897305,724Feb 26 03:49 PM
FOSTER JAMES CChairman, President and CEOFeb 25Sale144.538,2851,197,433313,367Feb 26 03:48 PM
FOSTER JAMES CChairman, President and CEOFeb 25Sale144.326,295908,496321,652Feb 26 03:45 PM
Smith David RossCorporate Executive VP & CFOFeb 25Sale145.434,000581,71020,462Feb 26 04:03 PM
Smith David RossCorporate Executive VP & CFOFeb 25Sale144.554,210608,57524,462Feb 26 04:02 PM
MILNE GEORGE M JRDirectorFeb 22Option Exercise33.934,540154,04228,883Feb 25 10:12 AM
MILNE GEORGE M JRDirectorFeb 22Sale143.004,540649,22024,343Feb 25 10:12 AM
CHUBB STEPHEN DDirectorFeb 19Option Exercise33.934,540154,04238,868Feb 21 09:14 AM
CHUBB STEPHEN DDirectorFeb 19Sale141.234,540641,19134,328Feb 21 09:14 AM
FOSTER JAMES CChairman, President and CEOJan 08Sale115.0025,0002,875,000235,771Jan 10 09:05 AM
FOSTER JAMES CChairman, President and CEODec 10Option Exercise73.7025,1231,851,565310,894Dec 12 12:09 PM
FOSTER JAMES CChairman, President and CEODec 10Sale129.111,977255,252285,771Dec 12 12:19 PM
FOSTER JAMES CChairman, President and CEODec 10Sale127.473,668467,555291,416Dec 12 12:17 PM
FOSTER JAMES CChairman, President and CEODec 10Sale126.733,981504,523299,204Dec 12 12:16 PM
FOSTER JAMES CChairman, President and CEODec 10Sale126.414,308544,567303,185Dec 12 12:14 PM
FOSTER JAMES CChairman, President and CEODec 10Sale128.253,668470,416287,748Dec 12 12:12 PM
FOSTER JAMES CChairman, President and CEODec 10Sale127.104,120523,650295,084Dec 12 12:11 PM
FOSTER JAMES CChairman, President and CEODec 10Sale126.053,401428,690307,493Dec 12 12:09 PM